Giovanni Spagnolli

Giovanni Spagnolli is Chief Technology Officer at Sybilla Biotech, where he leads development of computational and structural biology platforms to identify druggable cryptic binding sites and enable novel therapeutic approaches. His expertise lies at the intersection of biophysics, computational biology, and drug discovery, with a focus on translating advanced scientific methodologies into scalable discovery technologies.